InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Natarajan Sethuraman
4 May 2026
President, Research & Develop.
Sold on a plan
25,907
$15.39
$398.81K
Kory James Wentworth
1 Apr 2026
Chief Financial Officer
Sold on a plan
2,500
$12.95
$32.38K
Kory James Wentworth
10 Mar 2026
Chief Financial Officer
Sold on a plan
11,388
$13.02
$148.22K
Nathan J Dowden
10 Mar 2026
President & COO
Sold on a plan
11,894
$13.05
$155.19K
Kory James Wentworth
9 Mar 2026
Chief Financial Officer
Sold on a plan
5,089
$13.00
$66.16K
Nathan J Dowden
9 Mar 2026
President & COO
Sold on a plan
3,116
$13.02
$40.58K
Kory James Wentworth
4 Mar 2026
Chief Financial Officer
Sold on a plan
7,988
$12.25
$97.89K
Kory James Wentworth
21 Nov 2025
Chief Financial Officer
Sold on a plan
8,910
$9.98
$88.93K
Show all 61 transactions →

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 1
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 396,101
History held since 1 Nov 2021